4 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 11.8% per year over the past 3 years.
Net income has grown slower than revenue (-24.1% vs -11.8% per year).
Operating margin has expanded, at 26.6% in the latest year.
Financial health
Total debt ($1.1B) exceeds cash ($248M); net debt is $890M.
Total debt has grown faster than revenue (40.2% vs -11.8% per year).
Total debt is 2.3× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$1.1B
$179M
0.0%
26.6%
9.0%
4.5%
-$25M
$1.1B
$248M
2024
$806M
-$139M
0.0%
-8.0%
-9.2%
-4.5%
$10M
$859M
$81M
2023
$1.0B
$124M
0.0%
23.9%
9.6%
4.6%
$59M
$579M
$105M
2022
$1.7B
$410M
0.0%
18.3%
39.6%
—
—
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$322M
$76M
0.0%
37.7%
3.3%
1.8%
$23M
$1.2B
$152M
Mar '26
$377M
$44M
0.0%
22.8%
2.0%
1.1%
-$35M
$1.3B
$289M
Dec '25
$258M
$70M
0.0%
39.0%
3.5%
1.8%
-$22M
$1.1B
$248M
Sep '25
$200M
$77M
0.0%
41.2%
4.3%
2.7%
-$127M
$487M
$83M
Jun '25
$269M
$108M
0.0%
60.1%
6.8%
3.4%
$23M
$200M
$21M
Mar '25
$272M
-$82M
0.0%
-36.7%
-5.5%
-2.6%
-$41M
$200M
$15M
Dec '24
$185M
-$57M
0.0%
-30.5%
-3.8%
-1.9%
-$4M
$859M
$81M
Sep '24
$133M
$13M
0.0%
-15.7%
0.8%
0.6%
$12M
$190M
$31M
Jun '24
$134M
-$60M
0.0%
-32.2%
-5.0%
—
—
—
—
Mar '24
$156M
-$39M
0.0%
-22.1%
-3.1%
—
—
—
—
Dec '23
$188M
$38M
0.0%
31.1%
2.9%
1.4%
—
$579M
$105M
Sep '23
$182M
$19M
0.0%
-2.9%
1.4%
—
—
—
$54M
Jun '23
—
-$35M
—
—
-3.2%
—
—
—
—
Mar '23
—
$96M
—
—
8.3%
—
—
—
—
Valuation over time
How the market has priced BKV against its own fundamentals since 2024-09 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 16.1× (Sep '24) to 16.1× (Sep '26).
The price-to-sales ratio has risen from 2.0× (Sep '24) to 2.5× (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is BKV growing its revenue and profit?
Over the past 3 years, Bkv Corp's revenue has declined 11.8% per year, and net income declined 24.1% per year. These are computed facts, not advice.
How much debt does BKV have?
As of FY2025, Bkv Corp reported $1.1B of total debt against $248M of cash.
What is BKV's profit margin?
In FY2025, gross margin was —, operating margin 26.6%, and net margin 15.7%.
What is BKV's P/E ratio?
As of Sep '26, Bkv Corp traded at a price-to-earnings ratio of about 16.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.